This year, some of our TRR259 members were also there to present their research work:
Dr. Mohammed Rabiul Hosen:
Presentation: “Preclinical testing of bioengineered cells and tissue therapies in cardiovascular disease”
Poster: “Circulating microRNA-122-5p correlates with improvement in left-ventricular function after transcatheter aortic valve replacement and regulates viability of cardiomyocytes via extracellular vesicles”
Poster. “Coronary artery disease ameliorates extracellular vesicle lncRNA PUNISHER regulates angiogenic response and endothelial cells function via NFkB-dependent mechanism”
Katharina Maus:
Poster: "Investigation of the role of long non-coding RNA H19 on endothelial to mesenchymal transition in aortic valve stenosis"
Nicola Willemsen:
Poster: "The Role of Toll-Like Receptor 3 in the Development of Aortic Valve Stenosis"
AHA 2022 TRR259 members at the AHA 2022
Annual Heart Meeting 2022
The Annual Meeting of the Scientific Sessions of the American Heart Association (AHA) was held at McCormick Place Convention Center, Chicago, Illinois USA from Saturday, Nov 05 through Monday, 07 Nov.
The American Heart Association (AHA) is a nonprofit organization in the United States that funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke.
The AHA conference takes place annually. The meeting provided an invaluable educational experience and an opportunity to network with top minds in the field, as well as a global community of more than 28000 Medical and Cardiology professionals from every subspecialty.
